Table 20-1
Pharmaceutical and medicine manufacturing — Balance sheet and income statement

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Archived

This page has been archived on the Web.

PDF Symbols  Next table  Previous table

Pharmaceutical and medicine manufacturing — Balance sheet and income statement
Table summary
This table displays the balance sheet and income statement data. The row headers provide information on the type of accounts in the balance sheet and income statement. The column headers provide a yearly breakdown for the five years covered in this tabulation. The values are reported in millions of dollars.
  2009 2010 2011 2012 2013
  millions of dollars
Balance sheet  
Assets 21,053 22,644 21,040 22,830 23,338
Cash and deposits 839 961 907 1,112 1,141
Accounts receivable and accrued revenue 2,871 2,635 3,098 3,473 3,187
Inventories 3,229 2,436 2,368 2,418 2,596
Investments 9,342 12,934 10,709 12,012 11,951
Investments and accounts with affiliates 7,295 10,673 10,615 11,870 11,881
Portfolio investments 2,047 2,261 94 141 70
Loans 10 14 19 18 34
Mortgages 6 13 12 11 16
Non-mortgages 4 2 7 7 18
Bank customers' liabilities under acceptances .. .. .. .. ..
Capital assets, net 2,868 2,668 2,458 2,420 2,465
Other assets 1,894 997 1,481 1,377 1,963
Liabilities 9,826 11,634 12,459 13,582 14,699
Accounts payable and accrued liabilities 4,759 5,474 5,164 5,757 5,762
Loans and accounts with affiliates 4,118 3,532 4,110 4,483 4,973
Borrowings 1,127 2,013 2,035 2,091 2,358
Loans and other borrowings 572 720 1,690 1,811 2,029
Bankers' acceptances and paper .. .. .. .. ..
Bonds and debentures 323 203 102 95 95
Mortgages 232 1,089 243 185 234
Future income taxes -73 105 158 -7 5
Bank customers' liabilities under acceptances .. .. .. .. ..
Other liabilities -105 510 993 1,258 1,601
Equity 11,227 11,010 8,581 9,248 8,638
Share capital 8,299 11,938 9,812 9,820 9,924
Contributed surplus and other 522 501 525 501 593
Retained earnings 2,406 -1,429 -1,757 -1,073 -1,878
Income statement  
Operating revenue 12,642 10,583 9,599 9,920 9,786
Sales of goods and services 12,149 10,263 8,993 9,339 9,425
Interest and dividend revenue (operating) .. .. .. .. ..
Other operating revenue 493 320 606 581 361
Operating expenses 11,528 9,549 8,409 8,996 9,188
Purchased goods, materials and service 8,641 7,116 6,060 6,408 6,745
Wages, salaries and employee benefits 2,423 1,981 1,925 2,111 2,038
Indirect taxes 39 28 29 31 30
Depreciation, depletion and amortization 359 383 353 357 372
Interest expense (operating) .. .. .. .. ..
Other operating expenses 67 40 42 88 4
Operating profit/loss 1,114 1,034 1,189 924 597
Interest and dividend revenue 36 190 15 13 22
Interest expense on borrowing 210 213 242 278 374
Gains/losses -18 257 44 -59 6
Profit before income tax 923 1,269 1,006 601 252
Income tax 221 234 289 111 71
Equity in affiliates' earnings 2 61 59 44 0
Profit before extraordinary gains 705 1,096 776 533 181
Extraordinary gains 0 -2 0 -1 -4
Net profit 705 1,094 776 533 178
Date modified: